Home › Companies › AngioDynamics, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and AngioDynamics, Inc.’s Form 8-K, filed 2025-11-12 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore AngioDynamics, Inc. in the interactive database Compare manager voting policies
These tallies are AngioDynamics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-11-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: James C. Clemmer | 29,634,152 | -- | -- | 800,454 | 5,462,943 | Majority: yes |
| Elect Director: Michael E. Tarnoff, MD | 29,245,896 | -- | -- | 1,188,710 | 5,462,943 | Majority: yes |
| Proposal 2: The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2026 was approved based upon the following votes: | 35,727,186 | 156,899 | 13,464 | -- | -- | Passed |
| Proposal 3: The proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers was approved based upon the following votes: | 28,357,782 | 2,057,982 | 18,842 | -- | 5,462,943 | Passed |
Source: AngioDynamics, Inc., Form 8-K, filed with the SEC on 2025-11-12 — read the filing on EDGAR.
Each item below shows how the 189 asset managers that disclosed a AngioDynamics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 8 wordings of this item as funds reported it.
93% Passed · of votes cast
AngioDynamics, Inc.’s own tally for this item (“Proposal 3: The proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers was approved based upon the following votes:”): 28,357,782 for, 2,057,982 against — passed, per its Form 8-K filed 2025-11-12 (Item 5.07). Of all 41,004,249 outstanding shares: 69% for, 5% against (74% of the company cast a for/against vote).
The 186 asset managers below cast 96% of the shares they voted on this item FOR (27,874,200 for, 1,057,074 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,161,012 | 400 | 0 | 0 | For |
| Vanguard | 2,149,574 | 0 | 0 | 0 | For |
| Point72 | 2,090,346 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 1,432,100 | 0 | 0 | 0 | For |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 1,383,060 | 12,605 | 0 | 0 | For |
| Divisadero Street Capital Management, LP | 1,387,470 | 0 | 0 | 0 | For |
| Fidelity | 1,083,891 | 0 | 0 | 0 | For |
| Nuveen | 1,015,147 | 0 | 0 | 0 | For |
| TIAA | 1,012,627 | 0 | 0 | 0 | For |
| Royce | 992,360 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 987,473 | 0 | 0 | 0 | For |
| SEGALL BRYANT & HAMILL, LLC | 939,525 | 0 | 0 | 0 | For |
| State Street | 809,846 | 0 | 0 | 0 | For |
| Renaissance | 666,025 | 0 | 0 | 0 | For |
| Charles Schwab | 662,026 | 0 | 0 | 0 | For |
| Dimensional | 646,326 | 0 | 0 | 0 | For |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 518,200 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 517,284 | 0 | 0 | Against |
| Pier Capital, LLC | 453,953 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 408,061 | 0 | 0 | 0 | For |
| Manatuck Hill Partners, LLC | 333,058 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 322,747 | 0 | 0 | 0 | For |
| Invesco | 0 | 322,422 | 0 | 0 | Against |
| Transamerica | 304,000 | 0 | 0 | 0 | For |
| Northern Trust | 294,956 | 0 | 0 | 0 | For |
Showing the 25 largest of 186 asset managers. See all 186 in the interactive database.
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
AngioDynamics, Inc.’s own tally for this item (“Elect Director: James C. Clemmer”): 29,634,152 for, 800,454 withheld, per its Form 8-K filed 2025-11-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 41,004,249 outstanding shares: 72% for, 2% withheld (74% of the company cast a for/withheld vote).
The 53 asset managers below cast 100% of the shares they voted on this item FOR (9,329,347 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,076,882 | 0 | 0 | 0 | For |
| BlackRock | 1,612,522 | 0 | 0 | 0 | For |
| TIAA | 1,012,627 | 0 | 0 | 0 | For |
| Fidelity | 991,096 | 0 | 0 | 0 | For |
| Royce | 553,461 | 0 | 0 | 0 | For |
| Dimensional | 499,017 | 0 | 0 | 0 | For |
| Charles Schwab | 330,988 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 322,747 | 0 | 0 | 0 | For |
| Transamerica | 304,000 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 243,221 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 200,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,902 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 119,724 | 0 | 0 | 0 | For |
| Equitable | 104,744 | 0 | 0 | 0 | For |
| American Century | 96,905 | 0 | 0 | 0 | For |
| State Street | 92,051 | 0 | 124 | 0 | For |
| Dunham Funds | 80,807 | 0 | 0 | 0 | For |
| 1290 Funds | 72,465 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 69,058 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,995 | 0 | 0 | 0 | For |
| Goldman Sachs | 54,264 | 0 | 0 | 0 | For |
| SEI | 51,777 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 31,109 | 0 | 0 | 0 | For |
| Northern Trust | 25,376 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 20,054 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
AngioDynamics, Inc.’s own tally for this item (“Elect Director: Michael E. Tarnoff, MD”): 29,245,896 for, 1,188,710 withheld, per its Form 8-K filed 2025-11-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 41,004,249 outstanding shares: 71% for, 3% withheld (74% of the company cast a for/withheld vote).
The 53 asset managers below cast 100% of the shares they voted on this item FOR (9,317,830 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,076,882 | 0 | 0 | 0 | For |
| BlackRock | 1,612,522 | 0 | 0 | 0 | For |
| TIAA | 1,012,627 | 0 | 0 | 0 | For |
| Fidelity | 991,096 | 0 | 0 | 0 | For |
| Royce | 553,461 | 0 | 0 | 0 | For |
| Dimensional | 499,017 | 0 | 0 | 0 | For |
| Charles Schwab | 330,988 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 322,747 | 0 | 0 | 0 | For |
| Transamerica | 304,000 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 243,221 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 200,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,902 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 119,724 | 0 | 0 | 0 | For |
| Equitable | 104,744 | 0 | 0 | 0 | For |
| American Century | 96,905 | 0 | 0 | 0 | For |
| State Street | 92,051 | 0 | 124 | 0 | For |
| Dunham Funds | 80,807 | 0 | 0 | 0 | For |
| 1290 Funds | 72,465 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 69,058 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,995 | 0 | 0 | 0 | For |
| Goldman Sachs | 54,264 | 0 | 0 | 0 | For |
| SEI | 51,777 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 31,109 | 0 | 0 | 0 | For |
| Northern Trust | 25,376 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 20,054 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.5% Passed · of votes cast
AngioDynamics, Inc.’s own tally for this item (“Proposal 2: The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2026 was approved based upon the following vo”): 35,727,186 for, 156,899 against — passed, per its Form 8-K filed 2025-11-12 (Item 5.07). Of all 41,004,249 outstanding shares: 87% for, 0.4% against (88% of the company cast a for/against vote).
The 53 asset managers below cast 99.9% of the shares they voted on this item FOR (9,327,738 for, 3,043 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,076,882 | 0 | 0 | 0 | For |
| BlackRock | 1,612,522 | 0 | 0 | 0 | For |
| TIAA | 1,012,627 | 0 | 0 | 0 | For |
| Fidelity | 991,096 | 0 | 0 | 0 | For |
| Royce | 553,461 | 0 | 0 | 0 | For |
| Dimensional | 499,017 | 0 | 0 | 0 | For |
| Charles Schwab | 330,988 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 322,747 | 0 | 0 | 0 | For |
| Transamerica | 304,000 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 243,221 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 200,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,902 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 119,724 | 0 | 0 | 0 | For |
| Equitable | 104,744 | 0 | 0 | 0 | For |
| American Century | 96,905 | 0 | 0 | 0 | For |
| State Street | 92,175 | 0 | 0 | 0 | For |
| Dunham Funds | 80,807 | 0 | 0 | 0 | For |
| 1290 Funds | 72,465 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 69,058 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,995 | 0 | 0 | 0 | For |
| Goldman Sachs | 54,264 | 0 | 0 | 0 | For |
| SEI | 50,044 | 1,733 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 31,109 | 0 | 0 | 0 | For |
| Northern Trust | 25,376 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 20,054 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.
Ranked by the number of AngioDynamics, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 41,004,249 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 7.71% |
| 2 | Vanguard | 5.24% |
| 3 | Point72 | 5.10% |
| 4 | ARMISTICE CAPITAL, LLC | 3.49% |
| 5 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 3.40% |
| 6 | Divisadero Street Capital Management, LP | 3.38% |
| 7 | Fidelity | 2.64% |
| 8 | Nuveen | 2.48% |
| 9 | TIAA | 2.47% |
| 10 | Royce | 2.42% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 8.99% | 13F |
| Point72 | 7.76% | 13F |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 6.12% | 13G |
| Vanguard Group | 5.94% | 13F |
| KEVIN KOTLER | 5.91% | 13G |
| State Street | 3.25% | 13F |
| James C. Clemmer | 2.73% | DEF14A |
| Dimensional Fund Advisors | 2.31% | 13F |
| Renaissance Technologies | 1.96% | 13F |
| Millennium Management | 1.57% | 13F |
Percentages above are of 41,004,249 shares outstanding, as reported by AngioDynamics, Inc. on its Form 10-Q dated 2024-08-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AngioDynamics, Inc.’s 10-Q dated 2024-08-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At AngioDynamics, Inc.'s shareholder meeting held 2025-11-10, in the 2025-2026 proxy season, 189 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 795 separate fund positions. On the most widely held item on that ballot — Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. — the proposal passed with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AngioDynamics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-11-12.
AngioDynamics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).